Curr Opin Neurol 2002 Jun;15(3):267-70
Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Despite being acknowledged as an important component in the overall management of multiple sclerosis, the relatively few evaluative studies in symptomatic treatment and rehabilitation have meant that the evidence base is still poor.
The encouraging work on health outcome measures, together with an improved understanding of the mechanisms underlying disability, provide a useful base for improving the lot of patients with multiple sclerosis.
These advances need to be associated with improved models of care which provide comprehensive and accessible services throughout the course of the disease.